Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

16.37USD
16 Aug 2019
Change (% chg)

$0.26 (+1.61%)
Prev Close
$16.11
Open
$16.15
Day's High
$16.51
Day's Low
$15.94
Volume
24,394
Avg. Vol
51,984
52-wk High
$34.65
52-wk Low
$12.59

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Apr '19 2.93 -0.496
Jan '19 3.89 -0.230
Oct 5.59 -0.219
Jul 3.72 -0.466
FY 2018 Apr '18 4.84 -0.061
Jan '18 2.33 -0.485
Oct 1.13 -0.498
Jul 0.10 -0.507
FY 2017 Apr '17 0.11 -0.440
Jan '17 0.25 -0.998
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jan-19 5 4.25 5.40 3.00 --
Quarter Ending Apr-19 6 4.04 5.03 3.00 --
Year Ending Apr-19 6 16.82 17.40 15.30 --
Year Ending Apr-20 7 30.40 73.00 10.00 19.40
Year Ending Apr-21 6 28.39 140.10 0.00 10.00
Earnings (per share)
Quarter Ending Jan-19 5 -0.45 -0.23 -0.62 --
Quarter Ending Apr-19 6 -0.42 -0.28 -0.79 --
Year Ending Apr-19 6 -1.37 -1.16 -2.11 --
Year Ending Apr-20 6 -1.80 0.93 -3.71 -0.60
Year Ending Apr-21 6 -2.18 3.66 -3.83 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.89 32.67
P/E High - Last 5 Yrs. -- 42.97 47.29
P/E Low - Last 5 Yrs. -- 23.36 23.87
Beta -- 0.89 0.89
Price to Sales (TTM) 151.44 6.25 7.91
Price to Book (MRQ) 2.63 5.26 5.38
Price to Tangible Book (MRQ) 2.63 5.93 6.71
Price to Cash Flow (TTM) -- 23.51 24.37
% Owned Institutions 80.82 0.75 1.45

Dividends

  Company industry sector
Dividend Yield -- 1.42 1.35
Dividend Yield - 5 Year Avg -- 1.44 1.38
Dividend 5 Year Growth Rate -- 3.90 4.54
Payout Ratio(TTM) -- 42.60 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1,271.43 5.12 12.23
Sales (TTM) vs TTM 1 Yr. Ago 1,503.45 6.49 7.74
Sales - 5 Yr. Growth Rate -- 10.59 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.02 40.63 42.99
EPS (TTM) vs TTM 1 Yr. Ago 75.80 -- --
EPS - 5 Yr. Growth Rate -- 9.78 10.32
Capital Spending - 5 Yr. Growth Rate -- 15.44 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.21
Current Ratio (MRQ) 7.87 2.93 3.03
LT Debt to Equity (MRQ) 0.80 7.95 10.20
Total Debt to Equity (MRQ) 1.55 11.64 14.55
Interest Coverage (TTM) -29.72 33.56 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.87 52.25
Gross Margin - 5 Yr. Avg. -- 49.68 50.41
EBITD Margin (TTM) -4,520.00 -- --
EBITD - 5 Yr. Avg -- 17.37 13.13
Operating Margin (TTM) -4,529.25 13.83 6.92
Operating Margin - 5 Yr. Avg. -- 13.93 8.94
Pre-Tax Margin (TTM) -4,120.21 12.46 6.13
Pre-Tax Margin - 5 Yr. Avg. -- 14.33 9.23
Net Profit Margin (TTM) -4,120.21 9.25 2.76
Net Profit Margin - 5 Yr. Avg. -- 10.77 5.60
Effective Tax Rate (TTM) -- 22.43 22.40
Effective Tax Rate - 5 Yr. Avg. -- 22.49 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 992,941,231 887,145,970
Net Income/Employee (TTM) -- 114,013,903 101,828,577
Receivable Turnover (TTM) -- 5.96 5.93
Inventory Turnover (TTM) -- 2.62 3.36
Asset Turnover (TTM) 0.01 0.97 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -55.70 11.51 11.17
Return on Assets - 5 Yr. Avg. -- 12.96 12.34
Return on Investment (TTM) -60.80 14.89 14.48
Return on Investment - 5 Yr. Avg. -- 16.86 16.02
Return on Equity (TTM) -61.05 16.01 15.78
Return on Equity - 5 Yr. Avg. -- 17.66 17.01
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kalvista Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -12.01 -15.05 10 24
13 Week 1.40 -3.54 60 42
26 Week -3.33 -10.68 48 42
52 Week -4.10 -18.72 44 12
YTD 2.55 -9.94 47 38
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 90.19%
# of Holders: 109
Total Shares Held: 15,683,368
3 Mo. Net Change: 864,452
# New Positions: 36
# Closed Positions: 21
# Increased Positions: 66
# Reduced Positions: 45
# Net Buyers: 21
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.